Price
$95.18+19.04%1Y
1M+4.52%1Y+19.04%
Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.
Smart Score
Below average4/10
Value22
Quality75
Momentum39
Growth65
P/E (TTM)47.4
Market Cap$50.30B
1Y Return+19.04%
5Y Return-10.47%
Business Segments
Revenue split by product segment, from SEC XBRL filings.
Latest period: Q1 2026Total $1.65B (+6.15%)
●Transcatheter Mitral And Tricuspid Therapies grew +52.00% YoY●Surgical +10.08% YoY
SegmentLatestQoQYoY
- Transcatheter Aortic Valve Replacement$1.20B+4.12%+14.40%
- Surgical$276.2M-+10.08%
- Transcatheter Mitral And Tricuspid Therapies$175.1M+20.59%+52.00%
- Critical Care---
- Surgical Heart Valve Therapy---